James M Mock
CIK 1736359 · View on SEC EDGAR ↗
Insider
First SEC filing: June 8, 2026 · Latest: June 8, 2026
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 85 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
85 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 29, 2024 | MRNA | S | 1,420 | $42.79 | $60,762 | 11,066 Direct | -11.37% | Disposed | 234.7% (price as of 2026-08-20) |
| Oct. 7, 2024 | MRNA | S | 715 | $60.12 | $42,986 | 9,505 Direct | -7.00% | Disposed | 138.2% (price as of 2026-08-20) |
| Aug. 29, 2024 | MRNA | S | 162 | $78.03 | $12,641 | 8,767 Direct | -1.81% | Disposed | 83.6% (price as of 2026-08-20) |
| Aug. 28, 2024 | MRNA | S | 1,321 | $79.39 | $104,874 | 8,600 Direct | -13.32% | Disposed | 80.4% (price as of 2026-08-20) |
| July 8, 2024 | MRNA | S | 689 | $118.24 | $81,467 | 7,269 Direct | -8.66% | Disposed | 21.1% (price as of 2026-08-20) |
| June 3, 2024 | MRNA | S | 691 | $140.72 | $97,238 | 6,506 Direct | -9.60% | Disposed | 1.8% (price as of 2026-08-20) |
| May 29, 2024 | MRNA | S | 183 | $144.50 | $26,444 | 5,871 Direct | -3.02% | Disposed | -0.9% (price as of 2026-08-20) |
| May 28, 2024 | MRNA | S | 648 | $162.47 | $105,281 | 5,726 Direct | -10.17% | Disposed | -11.8% (price as of 2026-08-20) |
| April 8, 2024 | MRNA | S | 705 | $101.93 | $71,861 | 5,048 Direct | -12.25% | Disposed | 40.5% (price as of 2026-08-20) |
| Feb. 29, 2024 | MRNA | S | 647 | $94.57 | $61,187 | 4,300 Direct | -13.08% | Disposed | 51.5% (price as of 2026-08-20) |
| Jan. 8, 2024 | MRNA | S | 772 | $109.75 | $84,727 | 3,632 Direct | -17.53% | Disposed | 30.5% (price as of 2026-08-20) |
| Oct. 6, 2023 | MRNA | S | 2,858 | $102.50 | $292,945 | 2,952 Direct | -49.19% | Disposed | 39.7% (price as of 2026-08-20) |
| June 24, 2022 | RVTY | S 10b5-1 | 663 | $146.34 | $97,023 | 27,577 Direct | -2.35% | Disposed | -17.6% (price as of 2026-08-20) |
| June 24, 2022 | RVTY | S 10b5-1 | 2,290 | $145.78 | $333,836 | 28,240 Direct | -7.50% | Disposed | -17.3% (price as of 2026-08-20) |
| June 24, 2022 | RVTY | S 10b5-1 | 2,072 | $144.90 | $300,233 | 30,530 Direct | -6.36% | Disposed | -16.8% (price as of 2026-08-20) |
Showing latest 100 of 129 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 2, 2026 | MRNA | Restricted Stock Units | Common Stock (1,452) | — | — | 1,452 | Disposed |
| Aug. 28, 2025 | MRNA | Restricted Stock Units | Common Stock (329) | — | — | 329 | Disposed |
| Aug. 27, 2025 | MRNA | Restricted Stock Units | Common Stock (774) | — | — | 774 | Disposed |
| July 3, 2025 | MRNA | Restricted Stock Units | Common Stock (1,453) | — | — | 1,453 | Disposed |
| May 28, 2025 | MRNA | Restricted Stock Units | Common Stock (328) | — | — | 328 | Disposed |
| May 27, 2025 | MRNA | Restricted Stock Units | Common Stock (773) | — | — | 773 | Disposed |
| April 4, 2025 | MRNA | Restricted Stock Units | Common Stock (1,452) | — | — | 1,452 | Disposed |
| March 1, 2025 | MRNA | Restricted Stock Units | Common Stock (39,606) | — | — | 39,606 | Acquired |
| March 1, 2025 | MRNA | Stock Option (Right to Buy) | Common Stock (63,478) | $30.96 | March 1, 2035 | 63,478 | Acquired |
| Feb. 28, 2025 | MRNA | Restricted Stock Units | Common Stock (329) | — | — | 329 | Disposed |
| Feb. 27, 2025 | MRNA | Restricted Stock Units | Common Stock (1,326) | — | — | 1,326 | Disposed |
| Feb. 27, 2025 | MRNA | Restricted Stock Units | Common Stock (3,094) | — | — | 3,094 | Disposed |
| Feb. 27, 2025 | MRNA | Performance Stock Units | Common Stock (1,326) | — | — | 1,326 | Disposed |
| Jan. 3, 2025 | MRNA | Restricted Stock Units | Common Stock (1,453) | — | — | 1,453 | Disposed |
| Dec. 5, 2024 | MRNA | Restricted Stock Units | Common Stock (188,761) | $0.00 | — | 188,761 | Acquired |
| Nov. 27, 2024 | MRNA | Restricted Stock Units | Common Stock (1,326) | — | — | 1,326 | Disposed |
| Nov. 27, 2024 | MRNA | Restricted Stock Units | Common Stock (329) | — | — | 329 | Disposed |
| Nov. 27, 2024 | MRNA | Performance Stock Units | Common Stock (1,326) | — | — | 1,326 | Disposed |
| Oct. 4, 2024 | MRNA | Restricted Stock Units | Common Stock (1,453) | — | — | 1,453 | Disposed |
| Aug. 28, 2024 | MRNA | Restricted Stock Units | Common Stock (329) | — | — | 329 | Disposed |
| Aug. 27, 2024 | MRNA | Restricted Stock Units | Common Stock (1,326) | — | — | 1,326 | Disposed |
| Aug. 27, 2024 | MRNA | Performance Stock Units | Common Stock (1,326) | — | — | 1,326 | Disposed |
| July 5, 2024 | MRNA | Restricted Stock Units | Common Stock (1,452) | — | — | 1,452 | Disposed |
| May 31, 2024 | MRNA | Performance Stock Units | Common Stock (1,326) | — | — | 1,326 | Disposed |
| May 31, 2024 | MRNA | Performance Stock Units | Common Stock (5,304) | — | — | 5,304 | Acquired |
| May 28, 2024 | MRNA | Restricted Stock Units | Common Stock (328) | — | — | 328 | Disposed |
| May 24, 2024 | MRNA | Restricted Stock Units | Common Stock (1,326) | — | — | 1,326 | Disposed |
| April 5, 2024 | MRNA | Restricted Stock Units | Common Stock (1,453) | — | — | 1,453 | Disposed |
| Feb. 28, 2024 | MRNA | Restricted Stock Units | Common Stock (1,315) | — | — | 1,315 | Disposed |
| Feb. 27, 2024 | MRNA | Stock Option (Right to Buy) | Common Stock (23,635) | $96.20 | Feb. 27, 2034 | 23,635 | Acquired |
| Feb. 27, 2024 | MRNA | Restricted Stock Units | Common Stock (12,377) | $0.00 | — | 12,377 | Acquired |
| Feb. 27, 2024 | MRNA | Stock Option (Right to Buy) | Common Stock (60,216) | $96.20 | Feb. 27, 2034 | 60,216 | Acquired |
| Feb. 27, 2024 | MRNA | Restricted Stock Units | Common Stock (5,304) | $0.00 | — | 5,304 | Acquired |
| Jan. 5, 2024 | MRNA | Restricted Stock Units | Common Stock (1,452) | — | — | 1,452 | Disposed |
| Oct. 5, 2023 | MRNA | Restricted Stock Units | Common Stock (5,810) | — | — | 5,810 | Disposed |
| Feb. 28, 2023 | MRNA | Restricted Stock Units | Common Stock (5,260) | $0.00 | — | 5,260 | Acquired |
| Feb. 28, 2023 | MRNA | Stock Option (Right to Buy) | Common Stock (20,040) | $138.81 | Feb. 28, 2033 | 20,040 | Acquired |
| Oct. 5, 2022 | MRNA | Restricted Stock Units | Common Stock (23,242) | $0.00 | — | 23,242 | Acquired |
| Oct. 5, 2022 | MRNA | Stock Option (Right to Buy) | Common Stock (43,876) | $125.62 | Oct. 5, 2032 | 43,876 | Acquired |
| Feb. 4, 2022 | RVTY | NQ Stock Option (right to buy) | Common Stock (9,771) | $184.61 | Feb. 4, 2029 | 9,771 | Acquired |
| Feb. 5, 2021 | RVTY | NQ Stock Option (right to buy) | Common Stock (11,125) | $144.33 | Feb. 5, 2028 | 11,125 | Acquired |
| Jan. 30, 2020 | RVTY | NQ Stock Option (right to buy) | Common Stock (15,817) | $96.06 | Jan. 30, 2027 | 15,817 | Acquired |
| Feb. 5, 2019 | RVTY | NQ Stock Option (right to buy) | Common Stock (13,598) | $92.09 | Feb. 5, 2026 | 13,598 | Acquired |
| May 15, 2018 | RVTY | NQ Stock Option (right to buy) | Common Stock (17,038) | — | May 15, 2025 | 17,038 | Acquired |
| May 15, 2018 | RVTY | NQ Stock Option (right to buy) | Common Stock (17,038) | $73.83 | May 15, 2025 | 17,038 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2018 | $331,154 | $400,000 | — | — | $641,813 | — | $8,268 | $4,266,616 |
MRNA
CFO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $792,308 | — | — | — | $583,200 | — | $21,100 | $4,317,185 |
| 2022 | $227,885 | $1,000,000 | — | — | $259,644 | — | $4,327 | $7,331,196 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.